| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |